 |
| Opinion |  Top |
|
 |
|
| Editorials |
|
|
|
PDUFA: The US Senate should clean up its act p815
doi:10.1038/nbt0997-815a
PDF
(132K)
|
|
|
|
Gene therapy: Better vectors, less hype p815
doi:10.1038/nbt0997-815b
PDF
(132K)
|
|
 |
|
| Commentary |
|
|
|
Assessing the odds: The emergence of resistance to Bt transgenic plants pp816 - 817
Richard T. Roush
& Anthony M. Shelton
doi:10.1038/nbt0997-816
References | PDF
(385K)
|
|
|
|
Hedgehogs, foxes, and a new science p819
Charles DeLisi, Charles Cantor
& Zhiping Weng
doi:10.1038/nbt0997-819
References | PDF
(149K)
|
|
|
|
| Correspondence |
|
|
|
In defense of genomics p820
Tim Harris
& Alan Buckler
doi:10.1038/nbt0997-820
References | PDF
(360K)
|
|
|
|
Reply to 'In defense of genomics' p821
doi:10.1038/nbt0997-821
PDF
(210K)
|
|
| In Brief | Top |
|
|
|
| Business and Regulatory News |
|
|
|
Business & Regulatory News pp823 - 825
doi:10.1038/nbt0997-823
PDF
(620K)
|
|
|
|
| Research News |
|
|
|
Research News p826
doi:10.1038/nbt0997-826
PDF
(231K)
|
|
|
|
| This Month in Biotechnology |
|
|
|
This Month in Nature Biotechnolgy p827
doi:10.1038/nbt0997-827
PDF
(244K)
|
|
| Analysis | Top |
|
|
|
| Business and Regulatory News |
|
|
|
Phase II results in rheumatoid arthritis encouraging for Immunex p829
Vicki Brower
doi:10.1038/nbt0997-829a
PDF
(134K)
|
|
|
|
Genset−Abbott deal heralds pharmacogenomics era pp829 - 830
Andrew Marshall
doi:10.1038/nbt0997-829b
PDF
(275K)
|
|
|
|
Cyanamid let off lightly in litigation over vitamin formulation p831
Ken Chahine
& Bart Giddings
doi:10.1038/nbt0997-831
Abstract | PDF
(187K)
|
|
|
|
HIV vector challenges gene therapy oversight p832
Jeffrey L Fox
doi:10.1038/nbt0997-832
PDF
(205K)
|
|
|
|
"Gene," another landmark in farmyard cloning p833
Debra Robertson
doi:10.1038/nbt0997-833
PDF
(217K)
|
|
|
|
Human chorionic gonadotropin hoodwinks Gallo pp834 - 835
Thomas Hoff
doi:10.1038/nbt0997-834
PDF
(474K)
|
|
|
|
Off-and-on agbio ban raises free trade concerns p836
Emma Dorey
doi:10.1038/nbt0997-836
PDF
(191K)
|
|
|
|
ICH brings promise of "science-based" regulation p837
Barbara Nasto
doi:10.1038/nbt0997-837
PDF
(194K)
|
|
|
|
Minnows and academics hold up EPA rules p838
Jeffrey L. Fox
doi:10.1038/nbt0997-838
PDF
(190K)
|
|
|
|
| Research News |
|
|
|
Dysfunctional genomics: BACs to the rescue p839
Melvin I. Simon
doi:10.1038/nbt0997-839
References | PDF
(139K)
|
|
|
|
A marriage of viral vectors pp840 - 841
Richard G. Vile
doi:10.1038/nbt0997-840
References | PDF
(343K)
|
|
|
|
Elegantly presented DNA vaccines pp842 - 843
Jeffrey B. Ulmer
doi:10.1038/nbt0997-842
References | PDF
(305K)
|
|
|
|
Insect antifreezes come in from the cold p844
Choy Hew
doi:10.1038/nbt0997-844
References | PDF
(128K)
|
|
| Features | Top |
|
|
|
A model protocol to assess the risks of agricultural introductions pp845 - 848
John Barton, John Crandon, Donald Kennedy
& Henry Miller
doi:10.1038/nbt0997-845
Abstract + references | PDF
(598K)
|
|
|
|
Sustaining biotechnology education initiatives pp850 - 851
Desmond Mascarenhas
doi:10.1038/nbt0997-850
Abstract | PDF
(244K)
|
|
|
|
Europe's enthusiasm for entrepreneurism pp852 - 853
Riku Lähteenmäki, David Plant
& Adam Michael
doi:10.1038/nbt0997-852
Abstract | PDF
(257K)
|
|
| Research Review | Top |
|
|
|
Ancient DNA is thirteen years old pp855 - 858
Stéphane Audio
& Eliane Béraud-Colomb
doi:10.1038/nbt0997-855
Abstract + references | PDF
(549K)
|
|
| Research Articles | Top |
|
|
|
Homologous recombination based modification in Esherichia coli and germline transmission in transgenic mice of a bacterial artificial chromsome pp859 - 865
Xiangdong W. Yang, Peter Model
& Nathaniel Heintz
doi:10.1038/nbt0997-859
Abstract + references | PDF
(1,079K)
|
|
|
|
Stable in vivo gene transduction via a novel adenoviral/retroviral chimeric vector pp866 - 870
Meizhen Feng, William H. Jackson Jr., Corey K. Goldman, Claudine Rancourt, Minghui Wang, Sandra K. Dusing, Gene Siegal
& David T. Curiel
doi:10.1038/nbt0997-866
Abstract + references | PDF
(767K)
|
|
|
|
Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo pp871 - 875
Romain Zufferey, Dea Nagy, Ron J. Mandel, Luigi Naldini
& Didier Trono
doi:10.1038/nbt0997-871
Abstract + references | PDF
(748K)
|
|
|
|
Immunity to Plasmodium falciparum malaria sporozoites by somatic transgene immunization pp876 - 881
Mara Gerloni, W. Ripley Ballou, Rosario Billetta
& Maurizio Zanetti
doi:10.1038/nbt0997-876
Abstract + references | PDF
(790K)
|
|
|
|
Engineering vaccines with heterologous B and T cell epitopes using immunoglobulin genes pp882 - 886
Sidong Xiong, Mara Gerloni
& Maurizio Zanetti
doi:10.1038/nbt0997-882
Abstract + references | PDF
(673K)
|
|
|
|
The antifreeze potential of the spruce budworm thermal hysteresis protein pp887 - 890
Michael G. Tyshenko, Daniel Doucet, Peter L. Davies
& Virginia K. Walker
doi:10.1038/nbt0997-887
Abstract + references | PDF
(466K)
|
|
|
|
Site-specific dissection of substrate recognition by thrombin pp891 - 895
Alessandro Vindigni, Quoc D. Dang
& Enrico Di Cera
doi:10.1038/nbt0997-891
Abstract + references | PDF
(610K)
|
|
|
|
Apoptosis induced in mammalian cells by small peptides that functionally antagonize the Rb-regulated E2F transcription factor pp896 - 901
Lasantha R. Bandara, Rowena Girling
& Nicholas B. La Thangue
doi:10.1038/nbt0997-896
Abstract + references | PDF
(874K)
|
|
|
|
Evaluating and enhancing ribozyme reaction efficiency in mammalian cells pp902 - 905
Joshua T. Jones
& Bruce A. Sullenger
doi:10.1038/nbt0997-902
Abstract + references | PDF
(474K)
|
|
|
|
Rapid typing and elucidation of new secondary metabolites of intact cyanobacteria using MALDI-TOF mass spectrometry pp906 - 909
Marcel Erhard, Hans von Döhren
& Peter Jungblut
doi:10.1038/nbt0997-906
Abstract + references | PDF
(411K)
|
|
| Resources | Top |
|
|
|
| Patents |
|
|
|
Are ESTs patentable? pp911 - 912
Dorothy R. Auth
doi:10.1038/nbt0997-911
Abstract + references | PDF
(291K)
|
|
|
|
Patent applications in the area of fermentation p913
doi:10.1038/nbt0997-913
PDF
(329K)
|
|
|
|
| WWW Guide |
|
|
|
Protein structure prediction on the Web p915
Lorenzo Segovia
doi:10.1038/nbt0997-915
PDF
(211K)
|
|
|
|
| People |
|
|
|
People p917
doi:10.1038/nbt0997-917
PDF
(210K)
|
|
|
|
| New Products |
|
|
|
New Products p919
doi:10.1038/nbt0997-919
PDF
(182K)
|
|
|
|
| Industry Trends |
|
|
|
Ribozyme therapeutics pp921 - 922
Aris Persidis
doi:10.1038/nbt0997-921
Abstract + references | PDF
(383K)
|
|
|
Top |
|
|
